Cargando…
Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG)
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652496/ http://dx.doi.org/10.1186/2051-1426-3-S2-P447 |
| _version_ | 1782401766603620352 |
|---|---|
| author | Steinberg, Gary Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schreiber, Taylor Price, Melissa |
| author_facet | Steinberg, Gary Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schreiber, Taylor Price, Melissa |
| author_sort | Steinberg, Gary |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4652496 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46524962015-11-25 Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) Steinberg, Gary Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schreiber, Taylor Price, Melissa J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652496/ http://dx.doi.org/10.1186/2051-1426-3-S2-P447 Text en Copyright © 2015 Steinberg et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Steinberg, Gary Shore, Neal Karsh, Lawrence Bailen, James Woods, Michael Schreiber, Taylor Price, Melissa Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) |
| title | Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) |
| title_full | Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) |
| title_fullStr | Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) |
| title_full_unstemmed | Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) |
| title_short | Phase I study of patients with non-muscle invasive bladder cancer (NMIBC) treated with vesigenurtacel-L (HS-410) after Bacillus Calmette-Guérin (BCG) |
| title_sort | phase i study of patients with non-muscle invasive bladder cancer (nmibc) treated with vesigenurtacel-l (hs-410) after bacillus calmette-guérin (bcg) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652496/ http://dx.doi.org/10.1186/2051-1426-3-S2-P447 |
| work_keys_str_mv | AT steinberggary phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg AT shoreneal phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg AT karshlawrence phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg AT bailenjames phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg AT woodsmichael phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg AT schreibertaylor phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg AT pricemelissa phaseistudyofpatientswithnonmuscleinvasivebladdercancernmibctreatedwithvesigenurtacellhs410afterbacilluscalmetteguerinbcg |